J&J Win Highlights FDA's Impact On Hip Implant Cases
After a costly loss in its first trial, Johnson & Johnson subsidiary DePuy Inc. this week managed to even its record in metal-on-metal implant cases, and attorneys say a crucial difference...To view the full article, register now.
Already a subscriber? Click here to view full article